{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-021296","form_type":"8-K","ticker":"AYTU","cik":"0001385818","company_name":"AYTU BIOPHARMA, INC","filed_at":"2024-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.189034+00:00","generated_at":"2026-06-01T01:24:34.956588+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Aytu BioPharma annual meeting elects all directors, ratifies auditor, approves say-on-pay","bullets":["All five incumbent directors elected with majority votes; Joshua Disbrow received 2,111,846 for, 596,291 withheld.","Ratification of Grant Thornton as auditor for FY 2024 approved: 3,290,868 for, 683,165 against.","Non-binding advisory vote on executive compensation approved: 1,978,765 for, 659,394 against.","Quorum of 73% (4,037,162 shares) represented at the June 26, 2024 meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-021296","json":"https://secwatch.observer/filing/0001437749-24-021296.json","markdown":"https://secwatch.observer/filing/0001437749-24-021296.md","text":"https://secwatch.observer/filing/0001437749-24-021296.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1385818/000143774924021296/0001437749-24-021296-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1385818/000143774924021296/aytu20240607_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T01:24:34.956588+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}